194 related articles for article (PubMed ID: 20351777)
1. Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3.
Kim K; Kim KH; Cheong J
PLoS One; 2010 Mar; 5(3):e8649. PubMed ID: 20351777
[TBL] [Abstract][Full Text] [Related]
2. Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.
Bock CT; Toan NL; Koeberlein B; Song le H; Chin R; Zentgraf H; Kandolf R; Torresi J
Intervirology; 2008; 51(6):432-43. PubMed ID: 19321929
[TBL] [Abstract][Full Text] [Related]
3. The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.
Kido T; Ou JH; Lau YF
PLoS One; 2011; 6(7):e22979. PubMed ID: 21829568
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.
Wu YL; Peng XE; Zhu YB; Yan XL; Chen WN; Lin X
J Virol; 2016 Feb; 90(4):1729-40. PubMed ID: 26637457
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.
Kawaguchi T; Yoshida T; Harada M; Hisamoto T; Nagao Y; Ide T; Taniguchi E; Kumemura H; Hanada S; Maeyama M; Baba S; Koga H; Kumashiro R; Ueno T; Ogata H; Yoshimura A; Sata M
Am J Pathol; 2004 Nov; 165(5):1499-508. PubMed ID: 15509521
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.
Tsunematsu S; Suda G; Yamasaki K; Kimura M; Izumi T; Umemura M; Ito J; Sato F; Nakai M; Sho T; Morikawa K; Ogawa K; Tanaka Y; Watashi K; Wakita T; Sakamoto N
J Med Virol; 2017 Feb; 89(2):267-275. PubMed ID: 27459003
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis.
You H; Yuan D; Bi Y; Zhang N; Li Q; Tu T; Wei X; Lian Q; Yu T; Kong D; Yang X; Liu X; Liu X; Kong F; Zheng K; Tang R
Cell Commun Signal; 2021 Mar; 19(1):33. PubMed ID: 33722250
[TBL] [Abstract][Full Text] [Related]
8. HBx protein-mediated ATOH1 downregulation suppresses ARID2 expression and promotes hepatocellular carcinoma.
Gao Q; Wang K; Chen K; Liang L; Zheng Y; Zhang Y; Xiang J; Tang N
Cancer Sci; 2017 Jul; 108(7):1328-1337. PubMed ID: 28498550
[TBL] [Abstract][Full Text] [Related]
9. Hepatic STAMP2 decreases hepatitis B virus X protein-associated metabolic deregulation.
Kim HY; Cho HK; Yoo SK; Cheong JH
Exp Mol Med; 2012 Oct; 44(10):622-32. PubMed ID: 23095254
[TBL] [Abstract][Full Text] [Related]
10. Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines.
Lim HY; Han J; Yoon H; Jang KL
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298868
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma.
Yen CJ; Lin YJ; Yen CS; Tsai HW; Tsai TF; Chang KY; Huang WC; Lin PW; Chiang CW; Chang TT
PLoS One; 2012; 7(7):e41931. PubMed ID: 22848663
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
Yoo YG; Lee MO
J Biol Chem; 2004 Aug; 279(35):36242-9. PubMed ID: 15173177
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus core protein inhibits hepatitis B virus replication by downregulating HBx levels via Siah-1-mediated proteasomal degradation during coinfection.
Lee S; Yoon H; Han J; Jang KL
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34882535
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of β-catenin by hepatitis B virus X protein in HBV-infected human hepatocellular carcinomas.
Chen L; Hu L; Li L; Liu Y; Tu QQ; Chang YX; Yan HX; Wu MC; Wang HY
Front Med China; 2010 Dec; 4(4):399-411. PubMed ID: 21107751
[TBL] [Abstract][Full Text] [Related]
19. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.
Arzumanyan A; Sambandam V; Clayton MM; Choi SS; Xie G; Diehl AM; Yu DY; Feitelson MA
Cancer Res; 2012 Nov; 72(22):5912-20. PubMed ID: 22986746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]